Toggle navigation
Home
Search
Services
Blog
Contact
About
Early Therapeutics Development with Phase 2 Emphasis-261017102
The University of Chicago
Search grants from The University of Chicago
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Preclinical development of teixobactin, a new antibiotic
Humanized mice as a model to study the role of oxidized lipids in HIV-related cardiovascular disease
Molecular &Behavioral Effects of Low Level Mn Exposure
Inhibitory Deficits in Mania and Hyperdopaminiergic Mice
The role of CD4+ T cells in melanoma immunotherapy
Recently added grants:
Identification of Natural Compound Combinations for Prevention of Prostate Cancer
Molecular and Epigenetic Control of Wnt/b-catenin-mediated oncogenesis by KDM4B
Impact of the senescent bone marrow microenvironment in AML biology
The role of estrogen receptor in breast cancer outcomes and the effect of exposure history
Mechanistic Understanding for the Role of Lin28b in Pancreatic Cancer Progression
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA017102-011
Application #
6994625
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2004
Total Cost
Indirect Cost
Institution
Name
The University of Chicago
Department
Type
DUNS #
City
State
Country
Zip Code
Related projects
NIH 2005
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2004
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2003
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
NIH 2002
N01 CA
Early Therapeutics Development with Phase 2 Emphasis-261017102
/ The University of Chicago
Comments
Be the first to comment on this grant